<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00689871</url>
  </required_header>
  <id_info>
    <org_study_id>020056</org_study_id>
    <nct_id>NCT00689871</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <brief_summary>
    <textblock>
      Safety and effectiveness of Natrelleâ„¢ Cohesive Round Silicone-Filled Breast Implants in women
      undergoing primary augmentation, primary reconstruction, or revision of existing breast
      implants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1999</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local Complications</measure>
    <time_frame>10 years</time_frame>
    <description>By patient risk of complications occuring in at least 5% of patients in 1 or more cohorts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</measure>
    <time_frame>10 years</time_frame>
    <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">715</enrollment>
  <condition>Breast Augmentation</condition>
  <condition>Breast Reconstruction</condition>
  <condition>Revision of Augmentation or Reconstruction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Natrelle(TM) Silicone-Filled Breast Implants</intervention_name>
    <description>Breast implant surgery</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, age 18 years or older

          -  Seeking primary breast augmentation (i.e., no previous breast implant surgery)
             indicated for the following: patient dissatisfaction with size or shape of breast
             (e.g., mammary hypoplasia, asymmetry, ptosis, or aplasia

          -  Seeking primary breast reconstruction

          -  Seeking breast revision-augmentation

          -  Seeking breast revision-reconstruction

          -  Adequate tissue available to cover implants

          -  Patients at MRI designated sites must be willing to undergo MRI at their 1,3, 5, 7 and
             9-year follow-up visits (serial MRI). The patient must be eligible for MRI (for
             example, no implanted metal or metal devices and no history of severe claustrophobia
             that may make her ineligible for MRI).

        Exclusion Criteria:

          -  Advanced fibrocystic disease considered to be premalignant without accompanying
             subcutaneous mastectomy

          -  Existing carcinoma of the breast, without mastectomy

          -  Abscess or infection in the body at the time of enrollment

          -  Pregnant or nursing

          -  Have any disease, including uncontrolled diabetes (e.g., HbAIc &gt; 8%), that is
             clinically known to impact wound healing ability

          -  Show tissue characteristics that are clinically incompatible with mammaplasty, such as
             tissue damage resulting from radiation, inadequate tissue, compromised vascularity or
             ulceration

          -  Have, or under treatment for, any condition that may constitute an unwarranted
             surgical risk (e.g., unstable cardiac or pulmonary problems)

          -  Show psychological characteristics that may be incompatible with the surgical
             procedure and the prosthesis, such as inappropriate attitude or motivation (e.g., body
             dysmorphic disorder)

          -  Are not willing to undergo further surgery for revision, if medically required
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Spear SL, Murphy DK, Slicton A, Walker PS; Inamed Silicone Breast Implant U.S. Study Group. Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007 Dec;120(7 Suppl 1):8S-16S; discussion 17S-18S.</citation>
    <PMID>18090808</PMID>
  </results_reference>
  <results_reference>
    <citation>Gladfelter J, Murphy D. Breast augmentation motivations and satisfaction: a prospective study of more than 3,000 silicone implantations. Plast Surg Nurs. 2008 Oct-Dec;28(4):170-4; quiz 175-6. doi: 10.1097/PSN.0b013e31818ea7e0.</citation>
    <PMID>19092580</PMID>
  </results_reference>
  <results_reference>
    <citation>Murphy DK, Beckstrand M, Sarwer DB. A prospective, multi-center study of psychosocial outcomes after augmentation with natrelle silicone-filled breast implants. Ann Plast Surg. 2009 Feb;62(2):118-21. doi: 10.1097/SAP.0b013e31817f01f8.</citation>
    <PMID>19158517</PMID>
  </results_reference>
  <results_reference>
    <citation>Largent JA, Reisman NR, Kaplan HM, Oefelein MG, Jewell ML. Clinical trial outcomes of high- and extra high-profile breast implants. Aesthet Surg J. 2013 May;33(4):529-39. doi: 10.1177/1090820X13484035. Epub 2013 Apr 4. Review.</citation>
    <PMID>23559355</PMID>
  </results_reference>
  <results_reference>
    <citation>Namnoum JD, Largent J, Kaplan HM, Oefelein MG, Brown MH. Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg. 2013 Sep;66(9):1165-72. doi: 10.1016/j.bjps.2013.04.046. Epub 2013 May 9. Review.</citation>
    <PMID>23664574</PMID>
  </results_reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2008</study_first_submitted>
  <study_first_submitted_qc>June 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2008</study_first_posted>
  <results_first_submitted>December 19, 2011</results_first_submitted>
  <results_first_submitted_qc>December 19, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 23, 2012</results_first_posted>
  <last_update_submitted>October 6, 2014</last_update_submitted>
  <last_update_submitted_qc>October 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment: January 6, 1999-June 30, 2000 at multiple US sites</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Primary Augmentation</title>
          <description>All women implanted for an indication of primary breast augmentation</description>
        </group>
        <group group_id="P2">
          <title>Primary Reconstruction</title>
          <description>All women implanted for an indication of primary breast reconstruction</description>
        </group>
        <group group_id="P3">
          <title>Revision-augmentation</title>
          <description>All women implanted for revision of a breast augmentation</description>
        </group>
        <group group_id="P4">
          <title>Revision-reconstruction</title>
          <description>All women implanted for revision of a breast reconstruction</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="455">908 Implants</participants>
                <participants group_id="P2" count="98">127 Implants</participants>
                <participants group_id="P3" count="147">288 Implants</participants>
                <participants group_id="P4" count="15">25 Implants</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="280">35 Patients discontinued</participants>
                <participants group_id="P2" count="46">35 Patients discontinued</participants>
                <participants group_id="P3" count="74">28 Patients discontinued</participants>
                <participants group_id="P4" count="8">4 Patients discontinued</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="175"/>
                <participants group_id="P2" count="52"/>
                <participants group_id="P3" count="73"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="123"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="37"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Explanted of All Study Devices</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Primary Augmentation</title>
          <description>All women implanted for an indication of primary breast augmentation</description>
        </group>
        <group group_id="B2">
          <title>Primary Reconstruction</title>
          <description>All women implanted for an indication of primary breast reconstruction</description>
        </group>
        <group group_id="B3">
          <title>Revision-augmentation</title>
          <description>All women implanted for revision of a breast augmentation</description>
        </group>
        <group group_id="B4">
          <title>Revision-reconstruction</title>
          <description>All women implanted for revision of a breast reconstruction</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="455"/>
            <count group_id="B2" value="98"/>
            <count group_id="B3" value="147"/>
            <count group_id="B4" value="15"/>
            <count group_id="B5" value="715"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=40 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="319"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="390"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 40 and 60 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136"/>
                    <measurement group_id="B2" value="73"/>
                    <measurement group_id="B3" value="84"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="302"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=60 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="455"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="147"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="715"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Local Complications</title>
        <description>By patient risk of complications occuring in at least 5% of patients in 1 or more cohorts</description>
        <time_frame>10 years</time_frame>
        <population>all enrolled patients</population>
        <group_list>
          <group group_id="O1">
            <title>Primary Augmentation</title>
            <description>All women implanted for an indication of primary breast augmentation</description>
          </group>
          <group group_id="O2">
            <title>Primary Reconstruction</title>
            <description>All women implanted for an indication of primary breast reconstruction</description>
          </group>
          <group group_id="O3">
            <title>Revision-augmentation</title>
            <description>All women implanted for revision of a breast augmentation</description>
          </group>
          <group group_id="O4">
            <title>Revision-reconstruction</title>
            <description>All women implanted for revision of a breast reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Local Complications</title>
          <description>By patient risk of complications occuring in at least 5% of patients in 1 or more cohorts</description>
          <population>all enrolled patients</population>
          <units>percentage by patient</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="98"/>
                <count group_id="O3" value="147"/>
                <count group_id="O4" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Capsular Contracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.9" lower_limit="15.4" upper_limit="23.1"/>
                    <measurement group_id="O2" value="24.6" lower_limit="16.2" upper_limit="36.2"/>
                    <measurement group_id="O3" value="28.7" lower_limit="21.3" upper_limit="37.9"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5" lower_limit="8.7" upper_limit="15.0"/>
                    <measurement group_id="O2" value="6.8" lower_limit="2.8" upper_limit="16.1"/>
                    <measurement group_id="O3" value="11.7" lower_limit="7.1" upper_limit="18.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" lower_limit="6.8" upper_limit="12.4"/>
                    <measurement group_id="O2" value="7.1" lower_limit="3.5" upper_limit="14.4"/>
                    <measurement group_id="O3" value="8.2" lower_limit="4.6" upper_limit="14.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Implant Malposition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" lower_limit="4.8" upper_limit="9.7"/>
                    <measurement group_id="O2" value="2.3" lower_limit="0.6" upper_limit="8.9"/>
                    <measurement group_id="O3" value="6.0" lower_limit="3.1" upper_limit="11.7"/>
                    <measurement group_id="O4" value="13.3" lower_limit="1.7" upper_limit="40.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nipple Complications</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="4.3" upper_limit="9.1"/>
                    <measurement group_id="O2" value="3.3" lower_limit="1.1" upper_limit="9.8"/>
                    <measurement group_id="O3" value="1.4" lower_limit="0.3" upper_limit="5.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertrophic/Other Abnormal Scarring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" lower_limit="2.6" upper_limit="6.5"/>
                    <measurement group_id="O2" value="5.5" lower_limit="2.3" upper_limit="12.7"/>
                    <measurement group_id="O3" value="6.6" lower_limit="3.5" upper_limit="12.3"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asymmetry</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" lower_limit="2.0" upper_limit="5.6"/>
                    <measurement group_id="O2" value="23.2" lower_limit="15.4" upper_limit="33.9"/>
                    <measurement group_id="O3" value="6.5" lower_limit="3.2" upper_limit="12.8"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrinkling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="0.8" upper_limit="3.7"/>
                    <measurement group_id="O2" value="10.2" lower_limit="5.2" upper_limit="19.6"/>
                    <measurement group_id="O3" value="5.4" lower_limit="2.6" upper_limit="11.0"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Implant Palpability/Visibility</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="0.8" upper_limit="3.4"/>
                    <measurement group_id="O2" value="6.4" lower_limit="2.3" upper_limit="12.7"/>
                    <measurement group_id="O3" value="6.0" lower_limit="3.0" upper_limit="11.6"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroma/Fluid Accumulation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="0.9" upper_limit="3.4"/>
                    <measurement group_id="O2" value="2.3" lower_limit="0.3" upper_limit="15.4"/>
                    <measurement group_id="O3" value="6.0" lower_limit="3.0" upper_limit="11.6"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bruising</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" lower_limit="0.1" upper_limit="1.8"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0.1" upper_limit="7.1"/>
                    <measurement group_id="O3" value="3.0" lower_limit="1.1" upper_limit="7.8"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Rash</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.3" upper_limit="2.3"/>
                    <measurement group_id="O2" value="2.0" lower_limit="0.5" upper_limit="7.9"/>
                    <measurement group_id="O3" value="0.7" lower_limit="0.1" upper_limit="4.9"/>
                    <measurement group_id="O4" value="6.7" lower_limit="0.2" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</title>
        <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
        <time_frame>10 years</time_frame>
        <population>All patients who had a breast implant satisfaction rating</population>
        <group_list>
          <group group_id="O1">
            <title>Primary Augmentation</title>
            <description>All women implanted for an indication of primary breast augmentation</description>
          </group>
          <group group_id="O2">
            <title>Primary Reconstruction</title>
            <description>All women implanted for an indication of primary breast reconstruction</description>
          </group>
          <group group_id="O3">
            <title>Revision-augmentation</title>
            <description>All women implanted for revision of a breast augmentation</description>
          </group>
          <group group_id="O4">
            <title>Revision-reconstruction</title>
            <description>All women implanted for revision of a breast reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</title>
          <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
          <population>All patients who had a breast implant satisfaction rating</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="74"/>
                <count group_id="O4" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physician satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="0.7"/>
                    <measurement group_id="O2" value="4.7" spread="0.6"/>
                    <measurement group_id="O3" value="4.4" spread="1.1"/>
                    <measurement group_id="O4" value="4.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="0.7"/>
                    <measurement group_id="O2" value="4.6" spread="0.7"/>
                    <measurement group_id="O3" value="4.4" spread="1.2"/>
                    <measurement group_id="O4" value="4.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Primary Augmentation</title>
          <description>All women implanted for an indication of primary breast augmentation</description>
        </group>
        <group group_id="E2">
          <title>Primary Reconstruction</title>
          <description>All women implanted for an indication of primary breast reconstruction</description>
        </group>
        <group group_id="E3">
          <title>Revision-augmentation</title>
          <description>All women implanted for revision of a breast augmentation</description>
        </group>
        <group group_id="E4">
          <title>Revision-reconstruction</title>
          <description>All women implanted for revision of a breast reconstruction</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="455"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="455"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The timing of separate presentation or publication of the study by the PI is subject to mutual agreement in advance between the Sponsor and PI.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The Revision-reconstruction arm only had 15 patients enrolled, which makes the data for that arm difficult to interpret.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Allergan Medical</organization>
      <phone>(805) 961-5000</phone>
      <email>devicetrials@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

